Dr.Reema Bansal, Dr.Ankur, Dr.Spoorti Krishna Reddy Mandadi
Subscleral sclerectomy (SSS) is an effective treatment in types 1 and 2 uveal effusion syndrome (UES). It produces an anatomic improvement in approximately 83% of treated eyes after a single procedure and in about 96% after one or two procedures. We present a 47-year-old male with type 2 UES, who developed recurrence of choroidal effusion 3.5 years after primary SSS, and responded well to a revised SSS in opposite quadrants. Histological examination of the excised scleral window revealed thickened sclera with deposition of Alcian blue positive material, consistent with UES. Primary UES is caused by abnormalities of the sclera and increased resistance to transscleral fluid outflow. Chronic disease may lead to secondary retinal pigment epithelial (leopard spot) changes and permanently reduced visual acuity. Full thickness sclerectomies provide an exit for choroidal fluid and prevent visual loss.